Effects of 28-day simvastatin administration on emotional processing, reward learning, working memory, and salivary cortisol in healthy participants at-risk for depression: OxSTEP, an online experimental medicine trial
Open Access
- 22 May 2025
- journal article
- research article
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 55, e155
Abstract
Background: Statins are among the most prescribed medications worldwide. Both beneficial (e.g. antidepressant and pro-cognitive) and adverse (e.g. depressogenic and cognitive-impairing) mental health outcomes have been described in clinical studies. The underlying neuropsychological mechanisms, whether positive or negative, are, however, not established. Clarifying such activities has implications for the safe prescribing and repurposing potential of these drugs, especially in people with depression. Methods: In this double-blind, randomized, placebo-controlled experimental medicine study, we investigated the effects of simvastatin on emotional processing, reward learning, working memory, and waking salivary cortisol (WSC) in 101 people at-risk for depression due to reported high loneliness scores (mean 7.3 ± 1.2 on the UCLA scale). This trial was largely conducted during periods of social distancing due to the COVID-19 pandemic (July 2021–February 2023), and we employed a fully remote design within a UK-wide sample. Results: High retention rates, minimal outlier data, and typical main effects of task condition (e.g. emotion) were seen in all cognitive tasks, indicating this approach was comparable to in-person testing. After 28 days, we found no statistically significant differences (F’s < 3.0, p’s > 0.20) for any of the measures of emotional processing, reward learning, working memory, and WSC. Conclusions: Study results do not substantiate concerns regarding adverse neuropsychiatric events due to statins and support the safety of their prescribing in at-risk populations. Although other unmeasured cognitive processes may be involved, our null findings are also in line with more recent clinical evidence suggesting statins do not show antidepressant or pro-cognitive efficacy.Keywords
This publication has 77 references indexed in Scilit:
- Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort studyDiabetologia, 2024
- Effect of Adjunctive Simvastatin on Depressive Symptoms Among Adults With Treatment-Resistant DepressionJAMA Network Open, 2023
- An experimental medicine study of the effects of simvastatin on emotional processing, reward learning, verbal memory, and inflammation in healthy volunteersPsychopharmacology, 2022
- Association of Symptoms of Depression With Cardiovascular Disease and Mortality in Low-, Middle-, and High-Income CountriesJAMA Psychiatry, 2020
- Reward-Processing Behavior in Depressed Participants Relative to Healthy VolunteersJAMA Psychiatry, 2020
- Psychological Aspects of the COVID-19 PandemicJournal of General Internal Medicine, 2020
- Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatmentPsychopharmacology, 2020
- A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samplesNeuropsychology Review, 2018
- Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteersPsychopharmacology, 2009
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976